Methodological Concerns Regarding: "Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?"

Adgang til dokumentet

@article{dedd9fee397f4473be9fac37d58d7f93,

title = "Methodological Concerns Regarding: {"}Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?{"}",

author = "Ahlstr{\"o}m, {Magnus Glindvad}",

year = "2024",

month = aug,

day = "17",

doi = "10.1245/s10434-024-15944-z",

language = "English",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York LLC",

}

TY - JOUR

T1 - Methodological Concerns Regarding: "Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?"

AU - Ahlström, Magnus Glindvad

PY - 2024/8/17

Y1 - 2024/8/17

UR - http://www.scopus.com/inward/record.url?scp=85201434124&partnerID=8YFLogxK

U2 - 10.1245/s10434-024-15944-z

DO - 10.1245/s10434-024-15944-z

M3 - Journal article

C2 - 39154155

SN - 1068-9265

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

ER -